- Report
- November 2026
- 374 Pages
Global
From €5518EUR$5,850USD£4,629GBP
- Report
- November 2026
- 506 Pages
Global
From €5518EUR$5,850USD£4,629GBP
- Report
- November 2026
- 482 Pages
Global
From €5518EUR$5,850USD£4,629GBP
- Report
- February 2026
- 250 Pages
Global
From €4235EUR$4,490USD£3,553GBP
- Report
- February 2026
- 250 Pages
Global
From €4235EUR$4,490USD£3,553GBP
- Report
- February 2026
- 250 Pages
Global
From €4235EUR$4,490USD£3,553GBP
- Report
- February 2026
- 250 Pages
Global
From €4235EUR$4,490USD£3,553GBP
- Report
- February 2026
- 250 Pages
Global
From €4235EUR$4,490USD£3,553GBP
- Report
- February 2026
- 250 Pages
Global
From €4235EUR$4,490USD£3,553GBP
- Report
- February 2026
- 250 Pages
Global
From €4235EUR$4,490USD£3,553GBP
- Report
- January 2026
- 180 Pages
Global
From €4245EUR$4,500USD£3,561GBP
- Report
- September 2026
- 200 Pages
Global
From €7537EUR$7,990USD£6,322GBP
- Report
- April 2026
- 139 Pages
Global
From €3772EUR$3,999USD£3,164GBP
- Report
- April 2026
- 148 Pages
Global
From €3772EUR$3,999USD£3,164GBP
- Report
- October 2026
- 150 Pages
Global
From €4575EUR$4,850USD£3,838GBP
- Report
- July 2026
- 118 Pages
Global
From €16974EUR$17,995USD£14,239GBP
- Report
- April 2026
- 80 Pages
United States
From €5612EUR$5,950USD£4,708GBP
- Report
- April 2026
- 150 Pages
North America
From €3772EUR$3,999USD£3,164GBP
- Report
- February 2026
- 100 Pages
Australia
From €5612EUR$5,950USD£4,708GBP
- Report
- February 2026
- 100 Pages
Australia
From €3726EUR$3,950USD£3,126GBP

The Migraine Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Migraine drugs are used to treat the symptoms of migraine headaches, such as nausea, vomiting, and sensitivity to light and sound. These drugs can be divided into two categories: abortive and preventive. Abortive drugs are taken at the onset of a migraine attack to reduce the severity of symptoms, while preventive drugs are taken on a regular basis to reduce the frequency of migraine attacks. Common abortive drugs include triptans, ergot alkaloids, and non-steroidal anti-inflammatory drugs (NSAIDs). Common preventive drugs include beta-blockers, anticonvulsants, and serotonin receptor agonists.
Some companies in the Migraine Drug market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Allergan. Show Less Read more